| The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer W Xu, T Neill, Y Yang, Z Hu, E Cleveland, Y Wu, R Hutten, X Xiao, ... Gene therapy 22 (3), 247-256, 2015 | 91 | 2015 |
| Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases W Xu, Z Zhang, Y Yang, Z Hu, CH Wang, M Morgan, Y Wu, R Hutten, ... Molecular therapy 22 (8), 1504-1517, 2014 | 35 | 2014 |
| Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum SG Kelly, BO Taiwo, Y Wu, R Bhatia, CS Kettering, Y Gao, S Li, R Hutten, ... Journal of neurovirology 20, 514-520, 2014 | 20 | 2014 |
| Association of white matter hyperintensities with low serum 25-hydroxyvitamin D levels JM Prager, C Thomas, WJ Ankenbrandt, JR Meyer, Y Gao, A Ragin, ... American Journal of Neuroradiology 35 (6), 1145-1149, 2014 | 20 | 2014 |
| Predictors of distant failure after stereotactic body radiation therapy for stages I to IIA non–small-cell lung cancer CJ Miller, B Martin, K Stang, R Hutten, F Alite, C Small, B Emami, ... Clinical lung cancer 20 (1), 37-42, 2019 | 16 | 2019 |
| Radiation Oncology Virtual Education Rotation (ROVER) 2.0 for residents: implementation and outcomes NK Sandhu, E Rahimy, R Hutten, U Shukla, A Rajkumar-Calkins, JA Miller, ... Journal of Cancer Education 38 (3), 977-984, 2023 | 6 | 2023 |
| Racial and ethnic health disparities in delay to initiation of intensity-modulated radiotherapy RJ Hutten, CR Weil, DK Gaffney, K Kokeny, S Lloyd, CR Rogers, ... JCO Oncology Practice 18 (10), e1694-e1703, 2022 | 6 | 2022 |
| Patterns of care and treatment outcomes in locoregional squamous cell carcinoma of the prostate RJ Hutten, CR Weil, JD Tward, S Lloyd, SB Johnson European Urology Open Science 23, 30-33, 2021 | 5 | 2021 |
| The clinical significance of maximum tumor diameter on MRI in men undergoing radical prostatectomy or definitive radiotherapy for locoregional prostate cancer R Hutten, A Khouri, M Parsons, A Tward, T Wilson, J Peterson, G Morrell, ... Clinical Genitourinary Cancer 20 (6), e453-e459, 2022 | 4 | 2022 |
| Worsening racial disparities in utilization of intensity modulated radiation therapy RJ Hutten, CR Weil, DK Gaffney, K Kokeny, S Lloyd, CR Rogers, ... Advances in Radiation Oncology 7 (3), 100887, 2022 | 4 | 2022 |
| The effect of maximum tumor diameter by MRI on disease control in intermediate and high-risk prostate cancer patients treated with brachytherapy boost MW Parsons, RJ Hutten, A Tward, A Khouri, J Peterson, G Morrell, S Lloyd, ... Clinical Genitourinary Cancer 20 (1), e68-e74, 2022 | 4 | 2022 |
| Pretreatment factors influencing radiation pneumonitis after stereotactic body radiation therapy in the treatment of lung cancer AA Harris, K Stang, C Small, R Hutten, F Alite, B Emami, M Harkenrider Cureus 12 (3), 2020 | 3 | 2020 |
| Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Stages I-IIA Non–small Cell Lung Cancer: A Retrospective Analysis CJ Miller, K Stang, R Hutten, F Alite, C Small, B Emami, MM Harkenrider International Journal of Radiation Oncology, Biology, Physics 99 (2), E481-E482, 2017 | 2 | 2017 |
| Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine RJ Hutten, CR Weil, AJ King, B Barney, CL Bylund, A Fagerlin, ... JCO Oncology Practice 19 (11), 1000-1008, 2023 | 1 | 2023 |
| Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era JB Fenlon, RJ Hutten, SB Johnson, B Hu, H Shah, DM Stephens, A Maity, ... Leukemia & Lymphoma 64 (2), 356-363, 2023 | 1 | 2023 |
| Use patterns and perceptions of non-traditional therapies in radiotherapy patients: results from the multi-institutional Complementary and Alternative Medicine Exposure in … CR Weil, R Hutten, BM Barney, AS Fagerlin, DK Gaffney, D Gill, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e449, 2022 | 1 | 2022 |
| Second primary malignancies in diffuse large B-cell lymphoma survivors with 40 years of follow up: influence of chemotherapy and radiation therapy CB Rock, JJ Chipman, MW Parsons, CR Weil, RJ Hutten, R Tao, ... Advances in Radiation Oncology 7 (6), 101035, 2022 | 1 | 2022 |
| Feasibility and clinical utility of a workflow interfacing radiation oncology lung stereotactic body radiation therapy treatment planning and diagnostic radiology RJ Hutten, G Nelson, V Sarkar, SB Johnson, R Tao, Y Hitchcock, J Chan, ... Practical Radiation Oncology 12 (6), e512-e516, 2022 | 1 | 2022 |
| Patterns of care and outcomes of early stage I–II Hodgkin lymphoma treated with or without radiation therapy CR Weil, MJ Parsons, RJ Hutten, FH Lew, SB Johnson, DK Gaffney, ... Leukemia & Lymphoma 63 (12), 2847-2857, 2022 | 1 | 2022 |
| Achieving Health Equity in Radiation Oncology–Moving From Awareness to Action RJ Hutten, B Odei, A Rivera, G Suneja International Journal of Radiation Oncology, Biology, Physics 114 (2), 195-197, 2022 | 1 | 2022 |
